Economic Impact Analysis Highlights Millions in Potential Savings for Hospitals Using Etiometry Platform

Healthcare institutions utilizing Etiometry’s AI-driven clinical intelligence platform could see greater than 2X ROI in the first year and over $2 million in annual savings

BOSTON--(BUSINESS WIRE)--Etiometry, a leader in AI-driven clinical intelligence, released findings from a recent economic impact analysis highlighting the significant benefits of AI tools like the Etiometry Platform in improving outcomes and resource allocation in hospitals for critically ill patients. By leveraging advanced analytics and AI-powered insights, the platform empowers care teams to detect subtle changes in patient conditions, prevent complications, and improve recovery times, all leading to improved patient outcomes and reduced healthcare costs.

The economic impact estimates were generated using the Etiometry ROI tool, which leverages published clinical outcomes data and standardized healthcare cost assumptions. The analysis models a hospital with several intensive care units (ICUs) totaling 100 beds, offering a review of the potential economic value delivered by Etiometry.

The analysis demonstrates the following economic value of using Etiometry’s clinical decision support platform:

• ~ 200% return on investment (ROI) in year one
• ~ $2 million in annual savings
• More than $20,000 saved per ICU bed/year
• $3,541 - $9,109 estimated savings per patient

Cost savings are largely driven by reduced length of stay (LOS) and time on mechanical ventilation, with the added upside of freeing capacity to increase throughput and revenue. Extended LOS continues to be a significant challenge and critical metric for hospitals across the United States, putting pressure on margins and heightening clinical risk, particularly in the ICU where missed opportunities to escalate or de-escalate care in a timely manner can delay recovery and place further strain on hospital finances. According to Vizient subsidiary Sg2’s 2024 “Impact of Change” report, high-acuity hospital stays, which are the most resource-intensive, are increasing and projected to continue rising 13% by 2034, driven by the aging population and increase in comorbidities.

“With a potential cost savings of millions of dollars per year, the economic value of Etiometry’s solution is immense, and provides mutual benefit to both patients and hospitals,” said Shane Cooke, president and CEO of Etiometry. “Leveraging proven clinical analytics AI tools that demonstrate reducing LOS safely and effectively even a modest amount per patient can rapidly deliver substantial financial benefit across a hospital’s annual case volume.”

As the provider of the only commercially available solution that empowers care teams to make timely, data-driven decisions, detect subtle changes in patient conditions and improve outcomes, the Etiometry Platform has multiple FDA-cleared risk indices and clinical outcomes data that show how the platform is associated with reduced LOS.

Etiometry personalizes each patient’s optimal recovery based on their diagnosis and procedures, continuously monitoring the patient’s trajectory using advanced AI algorithms developed by and exclusively available through the Etiometry Platform. Through automated care pathways, the platform assesses patient status in real time to identify when to escalate or de-escalate care, which may notify the clinical team or flag when hospital-defined criteria are met to prompt timely review. This approach has demonstrated significant improvements in both patient outcomes and financial performance, helping hospitals optimize care steps and ultimately move patients through their systems more efficiently.¹

Etiometry’s AI platform is already trusted at scale, helping health systems reduce LOS and ICU LOS. More than 50 leading hospitals using Etiometry across 3,500+ beds in roughly 150 ICUs spanning pediatric, academic and adult health systems, have reported:

• 36% reduction in ICU length of stay
• 41% reduction in ICU readmissions
• 30% less time on mechanical ventilation
• 29% decrease in vasoactive support
• 88% of nurses say it makes their jobs easier

With 10 FDA clearances, automated clinical pathways that support hospital-defined protocols and quality improvement analysis, Etiometry is harnessing the power of AI and advanced analytics to transform how hospitals treat complex patients.

For more information about Etiometry, visit Etiometry.com.

About Etiometry

Founded in 2010, Etiometry offers an AI-driven clinical intelligence platform designed to help critical care clinicians make data-driven, proactive decisions. By leveraging advanced analytics and AI-powered insights, the company empowers care teams to detect subtle changes in patient conditions, prevent complications, and improve recovery times.

Etiometry has received ten FDA clearances and is trusted by leading healthcare institutions worldwide, including top-ranked academic medical centers and pediatric hospitals. The company is committed to advancing patient safety, improving clinical efficiency, and lowering the cost of care through smarter data utilization.

To learn more, visit www.etiometry.com.

__________________

^1 The Etiometry Platform is not an active patient-monitoring or alarm system and does not diagnose or predict clinical events. Pathway outputs and indices provide partial quantitative information and must be interpreted with other clinical data; no clinical decisions should be based solely on these outputs.